{"id":"W2209281674","doi":"10.1002/hep.28422","title":"Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST‐2)","year":2015,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Janssen Biotech; GlaxoSmithKline; Exelixis; Eisai; Gilead Sciences; Bristol-Myers Squibb","keywords":"Simeprevir; Sofosbuvir; Medicine; Internal medicine; Cirrhosis; Gastroenterology; Ribavirin; Hepatitis C virus; Adverse effect; Clinical endpoint; Population; Hepatitis C; Virology; Virus; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002378607,0.00142872,0.00192598,0.0002870634,0.000365976,0.0007808961,0.0006933137,0.0009391601,0.002990603],"category_scores_gemma":[0.0006931141,0.0005332634,0.00197703,0.0002805408,0.0006221786,0.0005939527,0.0003271536,0.002374151,0.0006187128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006021329,"about_ca_system_score_gemma":0.001637275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009186906,"about_ca_topic_score_gemma":0.002146279,"domain_scores_codex":[0.9994841,0.0003027246,0.00002338952,0.00006137263,0.00004162013,0.0000868201],"domain_scores_gemma":[0.9994699,0.00008980943,0.000111062,0.00003681623,0.00003702792,0.0002553044],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.855495,0.05377097,0.009523278,0.0007492002,0.001331999,0.0001539453,0.0001954065,0.001484325,0.01356074,0.0001244657,0.001994592,0.06161609],"study_design_scores_gemma":[0.6958673,0.2854635,0.0148582,0.00003696858,0.0004047136,0.0001655231,0.00003280436,0.0009687596,0.001150757,0.00008297616,0.0009402004,0.00002825799],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944941,0.001728702,0.0002431855,0.0003206826,0.00007062409,0.001292982,0.0006676106,0.00006970418,0.001112235],"genre_scores_gemma":[0.9904917,0.001574574,0.001700299,0.001009373,0.000219908,0.001763855,0.001996012,0.00002556587,0.001218635],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002990603,"threshold_uncertainty_score":0.01257944,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03805192017903353,"score_gpt":0.3384012189590032,"score_spread":0.3003492987799697,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}